I have a strong interest and passion for uncovering the molecular mechanism(s) of early childhood neurodevelopmental disorders (NDDs) including epilepsy, intellectual disability and autism spectrum disorders (ASD). As a mother of a son with ASD, these debilitating conditions are very close to my heart. I am committed to working towards translating research outcomes to benefit those children and families who are affected by girls clustering epilepsy (GCE) and other NDDs.
Contribution to my field of research: I have made significant contributions in the field of cancer biology and human genetic diseases. I have published 11 papers, 7 research papers, 2 method papers and 2 book chapters. Over the last 5 years, I have published in high-ranking journals, including, Hum Mol Genet, Oncogene, Oncotarget and Eur J Hum Genet. My papers have been cited >120 times since 2012. I was the first to implicate a novel role of PCDH19, a cell communication cell adhesion molecule in gene expression. I am now turning my attention to discovery proteins and gene networks in relation to Girls Clustering Epilepsy.
Collaborations: I have maintained strong collaborative links with Prof Stuart Pitson and Dr Melissa Pitman (who is an expert in protein structure modelling) from the Centre for Cancer Biology and recently we have collaborated in the research project involving in silico and in vitro assessment of PCDH19 gene variations. I have recently established a collaboration network with Prof Sam Berkovic and Dr Slave Petrovski from the Epi4k consortium to have access to various different PCDH19 variants that are likely important in other developmental disorders involving epilepsies and intellectual disability, which we have, include in our studies.
|2017||Travel Grants Program||Robinson Research Institute, The University of Adelaide|
|2014||Best Primary Research Paper||Centre for Cancer Biology, UniSA|
|English||Can read, write, speak, understand spoken and peer review|
|Vietnamese||Can read, write, speak, understand spoken and peer review|
|University of Adelaide, Adelaide||Australia||PhD in Biomedical Sciences|
|University of South Australia, Adelaide||Australia||Bachelor of Health Science (Honours)|
|University of South Australia, Adelaide||Australia||Bachelor of Medical & Pharmaceutical Biotechnology|
|2017||Pham,D, Tan,C, Homan,C, Kolc,K, Corbett,M, McAninch,D, Fox,A, Thomas,P, Kumar,R, Gecz,J et al, 2017, Protocadherin 19 (PCDH19) interacts with paraspeckle protein NONO to co-regulate gene expression with estrogen receptor alpha (ERα), Human Molecular Genetics, 26, 11, 2042-2052 10.1093/hmg/ddx094|
|2016||Neubauer,H, Pham,D, Zebol,J, Moretti,P, Peterson,A, Leclercq,T, Chan,H, Powell,J, Pitman,M, Samuel,M et al, 2016, An oncogenic role for sphingosine kinase 2, Oncotarget, 7, 40, 64886-64899 10.18632/oncotarget.11714|
|2016||Kumar,R, Ha,T, Pham,D, Shaw,M, Mangelsdorf,M, Friend,K, Hobson,L, Turner,G, Boyle,J, Field,M et al, 2016, A non-coding variant in the 5' UTR of DLG3 attenuates protein translation to cause non-syndromic intellectual disability, European Journal of Human Genetics, 24, 11, 1612-1616 10.1038/ejhg.2016.46|
|2015||Pitman,M, Powell,J, Coolen,C, Moretti,P, Zebol,J, Pham,D, Finnie,J, Don,A, Ebert,L, Bonder,C et al, 2015, A selective ATP-competitive sphingosine kinase inhibitor demonstrates anti-cancer properties, Oncotarget, 6, 9, 7065-7083 10.18632/oncotarget.3178|
|2015||Tan,C, Shard,C, Ranieri,E, Hynes,K, Pham,D, Leach,D, Buchanan,G, Corbett,M, Shoubridge,C, Kumar,R et al, 2015, Mutations of protocadherin 19 in female epilepsy (PCDH19-FE) lead to allopregnanolone deficiency, Human Molecular Genetics, 24, 18, 5250-5259 10.1093/hmg/ddv245|
|2014||Pham,D, Powell,J, Gliddon,B, Moretti,P, Tsykin,A, Van der Hoek,M, Kenyon,R, Goodall,G, Pitson,S, 2014, Enhanced expression of transferrin receptor 1 contributes to oncogenic signalling by sphingosine kinase 1, Oncogene, 33, 48, 5559-5568 10.1038/onc.2013.502|
|2010||Woodcock,J, Ma,Y, Coolen,C, Pham,D, Jones,C, Lopez,A, Pitson,S, 2010, Sphingosine and FTY720 directly bind pro-survival 14-3-3 proteins to regulate their function, Cellular Signalling, 22, 9, 1291-1299 10.1016/j.cellsig.2010.04.004|
|2008||Pham,D, Moretti,P, Goodall,G, Pitson,S, 2008, Attenuation of leakiness in doxycycline-inducible expression via incorporation of 3 ' AU-rich mRNA destabilizing elements, Biotechniques, 45, 2, 155-162 10.2144/000112896|
|2016||Pham,D, Tan,C, Homan,C, Jolly,L, Gecz,J, 2016, Protocadherin Mutations in Neurodevelopmental Disorders, Elsevier, London, pp. 221-231 10.1016/B978-0-12-800109-7.00014-5|
|2013||Pitman,MR, Jarman,KE, Leclercq,TM, Pham,DH, Pitson,SM, 2013, Sphingosine Kinases: Biochemistry, Regulation, and Roles, Wiley, Hoboken, New Jersey; USA, pp. 153-183 10.1002/9781118531426.ch9|
|2012||Pitman,M, Pham,D, Pitson,S, 2012, Isoform-selective assays for sphingosine kinase activity, Springer, United States, pp. 21-31 10.1007/978-1-61779-800-9_2|
- 2016. Investigation of PCDH19 protein and gene networks in neurodevelopmental disorders. WCH Foundation Research Project Grant $75,000
- 2015. Genotype phenotype investigations in PCDH19-Female Epilepsy. WCH Foundation Research Project Grant $74,920
I am currently supervising a research assistant, co-supervising a PhD student Ms Kristy Kolc, guiding her in experimental techniques and research applications. During my tenure in the Neurogenetics research group I have supervised a placement student, co-supervised an honours student and have actively been involved in the development and training of other staff and research students in the group.
|2016||Member||Human Genetics Society of Australasia||Australia|
|2006||Member||Australian Society of Biochemistry and Molecular Biology (ASBMB)||Australia|
|2017||Council||Robinson Research Institute Early and Mid-Career Research Council (EMCRC)||Robinson Research Institute, The University of Adelaide||Australia|
|2016||Member||Adelaide protein group (part of the ASBMB)||Australian Society of Biochemistry and Molecular Biology (ASBMB)||Australia|